<?xml version="1.0"?>
<Articles JournalTitle="Journal of Pharmaceutical Care">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Journal of Pharmaceutical Care</JournalTitle>
      <Issn>2322-4630</Issn>
      <Volume>10</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2022</Year>
        <Month>10</Month>
        <Day>01</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Symptomatic and Promising Disease-Modifying Treatments for Dementia Syndromes</title>
    <FirstPage>94</FirstPage>
    <LastPage>96</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Fatemeh</FirstName>
        <LastName>Mohammadian</LastName>
        <affiliation locale="en_US">Department of Psychiatry, Roozbeh Hospital, Tehran University of medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Niayesh</FirstName>
        <LastName>Mohebbi</LastName>
        <affiliation locale="en_US">Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences AND Research Center for Rational Use of Drugs, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2022</Year>
        <Month>09</Month>
        <Day>24</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2022</Year>
        <Month>09</Month>
        <Day>24</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Dementia could be defined as a range of cognitive and behavioral symptoms, including memory loss, executive dysfunction, and change in personality, and a reduction in a person's ability to carry out daily activities. The most common types of dementia are Alzheimer's disease (AD), vascular dementia, mixed dementia, dementia with Lewy bodies, and frontotemporal dementia (1).
&#xD;

All currently approved treatments for dementia are symptomatic treatments that could influence cognitive and behavioral symptoms without changing the underlying neuropathological progression of the disease (2).</abstract>
    <web_url>https://jpc.tums.ac.ir/index.php/jpc/article/view/530</web_url>
  </Article>
</Articles>
